Lynn Stockwell - Sep 24, 2025 Form 3 Insider Report for Drugs Made In America Acquisition II Corp. (DMII)

Role: CEO & Exe. Chair of the Board, Director, 10%+ Owner
Signature: /s/ Lynn Stockwell
Stock symbol: DMII
Transactions as of: Sep 24, 2025
Transactions value $: $0
Form type: 3
Date filed: 9/24/2025, 05:43 PM
Previous filing: Feb 18, 2025
Next filing: Oct 1, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Stockwell Lynn	CEO & Exe. Chair of the Board, Director, 10%+ Owner	C/O DRUGS MADE IN AMERICA ACQSTN II CORP, 1 EAST BROWARD BOULEVARD, SUITE 700, FORT LAUDERDALE	/s/ Lynn Stockwell	2025-09-24	0001927032

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DMII	Ordinary Shares						14.4M	Sep 24, 2025	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of shares owned by Drugs Made In America Acquisition II LLC (the "sponsor""). Lynn Stockwood is the managing member of the sponsor and has voting and dispositive power over the shares owned by the sponsor. Ms. Stockwell disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest she may have therein, directly or indirectly.